FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,684,514 | +40.4% | 2,406,422 | +4.3% | 0.02% | +41.2% |
| Q2 2023 | $7,611,193 | +47.8% | 2,306,422 | +27.7% | 0.02% | +41.7% |
| Q1 2023 | $5,148,303 | -36.9% | 1,806,422 | +61.3% | 0.01% | -40.0% |
| Q4 2022 | $8,153,600 | -23.6% | 1,120,000 | -15.2% | 0.02% | -23.1% |
| Q3 2022 | $10,679,000 | +707.2% | 1,320,000 | +388.9% | 0.03% | +766.7% |
| Q2 2022 | $1,323,000 | -97.1% | 270,000 | -86.2% | 0.00% | -96.6% |
| Q1 2022 | $46,118,000 | +51.6% | 1,950,000 | +13.4% | 0.09% | +60.0% |
| Q4 2021 | $30,427,000 | -8.6% | 1,720,000 | +45.8% | 0.06% | -16.7% |
| Q3 2021 | $33,288,000 | – | 1,180,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 2,343,154 | $10,403,604 | 3.92% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,718,881 | $25,391,832 | 1.37% |
| COWEN AND COMPANY, LLC | 4,308,359 | $19,129,113 | 1.34% |
| RA Capital Management | 11,609,704 | $51,547,086 | 1.02% |
| RTW INVESTMENTS, LP | 5,818,804 | $25,835,490 | 0.54% |
| Acuitas Investments, LLC | 134,811 | $598,561 | 0.35% |
| Simplify Asset Management Inc. | 570,519 | $2,533,104 | 0.29% |
| Vivo Capital, LLC | 520,000 | $2,308,800 | 0.25% |
| BRANDYWINE MANAGERS, LLC | 26,127 | $116,004 | 0.20% |
| DENALI ADVISORS LLC | 70,600 | $313,464 | 0.11% |